Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Moodys
AstraZeneca
Colorcon
McKinsey

Last Updated: December 1, 2021

DrugPatentWatch Database Preview

Kvk Tech Company Profile


Email this page to a colleague

« Back to Dashboard

Summary for Kvk Tech
International Patents:35
US Patents:5
Tradenames:9
Ingredients:9
NDAs:13

Drugs and US Patents for Kvk Tech

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Kvk Tech PHENTERMINE HYDROCHLORIDE phentermine hydrochloride TABLET;ORAL 040876-001 Mar 31, 2008 AA RX No No ⤷  Try it Free ⤷  Try it Free
Kvk Tech HYDROXYZINE HYDROCHLORIDE hydroxyzine hydrochloride TABLET;ORAL 040786-003 Mar 20, 2007 AB RX No No ⤷  Try it Free ⤷  Try it Free
Kvk Tech PROMETHAZINE HYDROCHLORIDE promethazine hydrochloride TABLET;ORAL 040712-001 Jul 31, 2006 AB RX No No ⤷  Try it Free ⤷  Try it Free
Kvk Tech Inc APADAZ acetaminophen; benzhydrocodone hydrochloride TABLET;ORAL 208653-003 Jan 4, 2019 RX Yes Yes 8,461,137 ⤷  Try it Free Y Y ⤷  Try it Free
Kvk Tech Inc APADAZ acetaminophen; benzhydrocodone hydrochloride TABLET;ORAL 208653-003 Jan 4, 2019 RX Yes Yes 8,748,413 ⤷  Try it Free Y Y ⤷  Try it Free
Kvk Tech HYDROXYZINE HYDROCHLORIDE hydroxyzine hydrochloride TABLET;ORAL 040786-001 Mar 20, 2007 AB RX No No ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for Kvk Tech Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1758590 2017C/063 Belgium ⤷  Try it Free PRODUCT NAME: SEL DE SODIUM D'ACIDE DESOXYCHOLIQUE; AUTHORISATION NUMBER AND DATE: SE/H/1547/01/DC 20170612
1912999 14C0076 France ⤷  Try it Free PRODUCT NAME: SIMEPREVIR OU L'UN DE SES SELS, INCLUANT LE SEL DE SODIUM DE SIMEPREVIR; REGISTRATION NO/DATE: EU/1/14/924 20140516
0579826 SPC/GB02/042 United Kingdom ⤷  Try it Free PRODUCT NAME: ERTAPENEM ((1R,5S,6S,8R,2'S,4'S)-2-(2-(3-CARBOXYPHENYLCARBAMOYL)PYRROLIDIN-4-YLTHIO)-6-(1-HYDROXYETHYL)-1-METHYLCARBAPENEM-3-CARBOXYLIC ACID), A PHARMACEUTICALLY ACCEPTABLE SALT OR IN VIVO HYDROLYSABLE ESTER THEREOF, ESPECIALLY AS THE MONOSODIUM SALT ERTA; REGISTERED: UK EU/1/02/216/001 20020422
0480717 SPC/GB98/025 United Kingdom ⤷  Try it Free PRODUCT NAME: MONTELUKAST, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREFERABLY MONTELUKAST SODIUM; REGISTERED: FI 12766 19970825; FI 12767 19970825; UK 00025/0357 19980115; UK 00025/0358 19980115
1856135 LUC00153 Luxembourg ⤷  Try it Free PRODUCT NAME: FOSTAMATINIB OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE FOSTAMATINIB, OU UN HYDRATE, SOLVATE OU N-OXYDE DE FOSTAMATINIB OU LE SEL PHARMACEUTIQUEMENT ACCEPTABLE DE FOSTAMATINIB, EN PARTICULIER FOSTAMATINIB DISODIUM, EVENTUELLEMENT SOUS FORME D'HYDRATE; AUTHORISATION NUMBER AND DATE: EU/1/19/1405 20200113
0957929 SPC/GB06/021 United Kingdom ⤷  Try it Free PRODUCT NAME: PEGAPTANIB, PREFERABLY IN THE FORM OF ITS SODIUM SALT; REGISTERED: UK EU/1/05/325/001 20060201
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
McKinsey
Baxter
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.